Richard M. Schwartz, Ph.D.

Co-Founder, CMC Principal

About

I'm recognized as a manager with high ethics, values and trust. I am highly results oriented with a demonstrated organizational agility to bring groups together to achieve difficult objectives. I have a demonstrated ability to manage in a fast-paced evolving environment and lead programs in a matrix management structure and a broad perspective to understand the multi-disciplinary requirements of product development and how to build a development and manufacturing organization capable of growth and success. Senior-level "Technical Operations" responsibilities have included the development and manufacturing of cell therapy products, live and recombinant-based vaccines, protein therapeutics and synthetic biotics.

Country

United States

City

Cambridge

Industry

Biotechnology

Skill

Lifesciences, Biopharmaceuticals, Vaccines, Biotechnology, Science, Process Simulation, Technology Transfer, Monoclonal Antibodies, FDA, GMP, Cell, Purification, Protein Purification, Clinical Trials, Immunology, Molecular Biology, Microbiology, Laboratory, Protein Chemistry, Infectious Diseases

Experience

Co-Founder, CMC Principal

Consulting on the Green, LLC

2019-11 - Present · 6 yrs 11 mos

Lexington, Massachusetts, United States

Supporting clients with CMC expertise for vaccines, biologicals and gene therapy products.

Chief Technology Officer

Venture backed new company

2023-1 - 2024-5 · 1 yr 5 mos

Senior Vice President, Technical Operations

Vaxart, Inc.

2020-10 - 2022-5 · 1 yr 8 mos

South San Francisco, California, United States

Senior Vice President, Technical Operations

CRISPR Therapeutics

2018-7 - 2019-10 · 1 yr 4 mos

Cambridge, MA

Senior Vice President, Process Development and Manufacturing

Synlogic

2016-9 - 2018-7 · 1 yr 11 mos

Cambridge, MA

Chief, Vaccine Production Program Lab

Vaccine Research Center, NIAID, NIH

2008-5 - 2016-9 · 8 yrs 5 mos

Responsible for the Vaccine Production Program at the Vaccine Research Center, NIAID, NIH. We have on-going development programs in HIV (vaccines and mAbs), flu, chikungunya, RSV, equine encephalitis viruses and others.